Diversity of neuropsychiatric manifestations in systemic lupus erythematosus

• Main Author: Yuichiro Fujieda
• Format: Article
• Language: English
• Published: Taylor & Francis Group 2020-10-01
• Series: Immunological Medicine
• Subjects: systemic lupus erythematosus; neuropsychiatric lupus; post-steroid neuropsychiatric manifestation; antibodies against subunits of the n-methyl-d-aspartate receptor
• Online Access: http://dx.doi.org/10.1080/25785826.2020.1770947

Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterised by diverse organ damages resulting from various autoantibodies, such as antinuclear or anti-DNA antibodies. Neuropsychiatric lupus (NPSLE) refers to the neurological and psychiatric disorders complicated with SLE and can be challenging for physicians to manage. NPSLE has a broad spectrum and high heterogeneity of clinical phenotypes, including headaches, psychiatric symptoms and peripheral neuropathy. Additionally, various immune effectors have been reported to contribute to the pathogenesis, including cytokines, cell-mediated inflammation and brain-reactive autoantibodies. In some patients with SLE, neuropsychiatric symptoms develop for the first time after the initiation of the steroid treatment, hindering the differentiation from steroid psychosis. The administration of high doses of steroids in patients with SLE is believed to trigger psychiatric symptoms. No clear evidence has yet been found regarding the treatment of NPSLE. Therefore, NPSLE-specific markers need to be developed, and treatment guidelines should be established. This article provides an overview of NPSLE as well as its pathogenesis and treatment.